BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11571433)

  • 1. IL-15--friend or foe in transplantation rejection?
    Plunkett FJ; Akbar AN
    Transplantation; 2001 Sep; 72(5):771. PubMed ID: 11571433
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-15 is the main mediator of lymphocyte proliferation in cultures mixed with human kidney tubular epithelial cells.
    Lewis E; Weiler M; Chaimovitz C; Douvdevani A
    Transplantation; 2001 Sep; 72(5):886-90. PubMed ID: 11571455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 ligation enhances IL-15 production by tubular epithelial cells.
    Weiler M; Kachko L; Chaimovitz C; Kooten CV; Douvdevani A
    J Am Soc Nephrol; 2001 Jan; 12(1):80-87. PubMed ID: 11134253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
    Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
    Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of in vitro tissue-associated (mixed lymphocyte kidney culture) immunity by allograft rejection.
    Miller J; Esquenazi V; Olson L; Roth D; Milgrom M; Fuller L
    Transplant Proc; 1987 Feb; 19(1 Pt 1):263-4. PubMed ID: 2978902
    [No Abstract]   [Full Text] [Related]  

  • 6. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
    van der Mast BJ; van Besouw NM; de Kuiper P; Vaessen LM; Gregoor PJ; IJzermans JN; van Gelder T; Claas FH; Weimar W
    Transplantation; 2001 Sep; 72(5):873-80. PubMed ID: 11571453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection.
    Braun MY; McCormack A; Webb G; Batchelor JR
    Transplant Proc; 1993 Feb; 25(1 Pt 2):863-4. PubMed ID: 8442250
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up of CD8+ CD45RO+ DR+ T lymphocytes infiltrating the allograft after first-set rejection episodes in kidney transplants.
    Tkaczuk J; Rostaing L; Modesto A; Peres C; Bentouati L; Durand D; Abbal M; Suc JM; Ohayon E
    Transplant Proc; 1994 Feb; 26(1):235-6. PubMed ID: 8108954
    [No Abstract]   [Full Text] [Related]  

  • 9. In situ lymphoproliferation in renal transplant biopsies.
    Robertson H; Wheeler J; Thompson V; Johnson JS; Kirby JA; Morley AR
    Histochem Cell Biol; 1995 Oct; 104(4):331-4. PubMed ID: 8548567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of donor-specific blood transfusion on in vitro alloreactive precursor cell frequencies.
    Duffy B; Tyler J; Anderson C; Hanto D; Flye W; Rodey G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):753-4. PubMed ID: 2978930
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-transplant renal tubulitis: the recruitment, differentiation and persistence of intra-epithelial T cells.
    Robertson H; Kirby JA
    Am J Transplant; 2003 Jan; 3(1):3-10. PubMed ID: 12492703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human growth hormone augments responses in the mixed leukocyte culture.
    Benfield MR; Vail A; Weigent DA
    Transplant Proc; 1994 Feb; 26(1):84. PubMed ID: 8109034
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of kidney-specific peptides and their role in renal allograft rejection.
    Poindexter NJ; Naziruddin B; Oppat W; Flye MW; Mohanakumar T
    Transplant Proc; 1995 Feb; 27(1):900-2. PubMed ID: 7879223
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for clonal anergy as a mechanism responsible for the maintenance of transplantation tolerance.
    Braun MY; McCormack A; Webb G; Batchelor JR
    Eur J Immunol; 1993 Jul; 23(7):1462-8. PubMed ID: 8100772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of primed/memory CD8+ lymphocytes in vitro and in rejecting kidneys after transplantation.
    Akbar AN; Amlot PL; Timms A; Lombardi G; Lechler R; Janossy G
    Clin Exp Immunol; 1990 Aug; 81(2):225-31. PubMed ID: 1974831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubulitis after renal transplantation: demonstration of an association between CD103+ T cells, transforming growth factor beta1 expression and rejection grade.
    Robertson H; Wong WK; Talbot D; Burt AD; Kirby JA
    Transplantation; 2001 Jan; 71(2):306-13. PubMed ID: 11213078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific T cell lines grown from fine-needle aspirates of human renal allografts during acute rejection.
    Caillat S; Poisson J; Campos H; Debure A; Kreis H; Bach JF; Chatenoud L
    Transplantation; 1987 Aug; 44(2):325-9. PubMed ID: 2957833
    [No Abstract]   [Full Text] [Related]  

  • 18. Critical role of the calpain/calpastatin balance in acute allograft rejection.
    Letavernier E; Dansou B; Lochner M; Perez J; Bellocq A; Lindenmeyer MT; Cohen CD; Haymann JP; Eberl G; Baud L
    Eur J Immunol; 2011 Feb; 41(2):473-84. PubMed ID: 21268016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cells infiltrating rejected human kidney allografts secrete IFN-gamma, IL-6, and IL-10, and are modulated by IL-2 and IL-4.
    Merville P; Pouteil-Noble C; Wijdenes J; Potaux L; Touraine JL; Banchereau J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):111-3. PubMed ID: 8438243
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal allograft rejection. Tubular epithelial cells present alloantigen in the presence of costimulatory CD28 antibody.
    Wilson JL; Proud G; Forsythe JL; Taylor RM; Kirby JA
    Transplantation; 1995 Jan; 59(1):91-7. PubMed ID: 7530869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.